ArticleFrontiers in oncology2022

Case report: A case of heterogeneity of the antitumor response to immune checkpoint inhibitors in a patient with relapsed hepatocellular carcinoma.

Yingying Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.